Cav1
M. musculus
caveolin 1, caveolae protein
What the model saw
Gene: Cav1 Organism: Mus musculus Known functions: caveolin 1, caveolae protein. caveolin-1. ATPase binding. SNARE binding. enzyme binding. identical protein binding. inward rectifier potassium channel inhibitor activity. kinase binding. molecular adaptor activity. nitric-oxide synthase binding. nitric-oxide synthase inhibitor activity. oxysterol binding. peptidase activator activity. protein binding. protein heterodimerization activity. protein kinase binding. protein tyrosine kinase inhibitor activity. protein-containing complex binding. protein-macromolecule adaptor activity. receptor serine/threonine kinase binding. signaling receptor binding. small GTPase binding. transmembrane transporter binding.
View unredacted entry
caveolin 1, caveolae protein. caveolin-1. ATPase binding. SNARE binding. enzyme binding. identical protein binding. inward rectifier potassium channel inhibitor activity. kinase binding. molecular adaptor activity. nitric-oxide synthase binding. nitric-oxide synthase inhibitor activity. oxysterol binding. peptidase activator activity. protein binding. protein heterodimerization activity. protein kinase binding. protein tyrosine kinase inhibitor activity. protein-containing complex binding. protein-macromolecule adaptor activity. receptor serine/threonine kinase binding. signaling receptor binding. small GTPase binding. transmembrane transporter binding.
Solver output
Caveolin-1 (Cav1) is the principal structural protein of caveolae and acts as a scaffolding/inhibitory adaptor that suppresses multiple pro-survival signaling pathways. Its nitric-oxide synthase inhibitor activity reduces bioavailable NO, impairing endothelial function and vascular homeostasis. Cav1 is a well-established biomarker and effector of cellular senescence — it is strongly upregulated during replicative and stress-induced senescence and contributes to the senescence-associated secretory phenotype (SASP) by modulating p53/p21 and Ras/MAPK pathways. Its protein tyrosine kinase inhibitor activity dampens growth factor receptor signaling (e.g., EGFR, VEGFR), and its small GTPase binding suppresses Rac1/Ras-mediated proliferative and survival signals. Collectively, Cav1 overactivity promotes senescence entry and impairs tissue regeneration, making its normal function net anti-longevity in mice.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted anti_longevity with 0.72 confidence, but the ground truth is pro_longevity. The model's reasoning about Cav1 promoting senescence is partially grounded in real biology (Cav1 is indeed upregulated in senescent cells), but it drew the wrong conclusion about the net effect on longevity. In mice, Cav1 knockout studies show reduced lifespan and accelerated aging phenotypes, indicating Cav1 is pro-longevity. The model correctly identified some Cav1 biology (senescence association, NOS inhibition, kinase inhibitor activity) but misinterpreted the direction of effect — conflating Cav1's upregulation during senescence with it being a driver of aging rather than a protective/homeostatic factor. The mechanism reasoning is also incorrect in its conclusion.
Raw API responses
solver
{
"reasoning": "Caveolin-1 (Cav1) is the principal structural protein of caveolae and acts as a scaffolding/inhibitory adaptor that suppresses multiple pro-survival signaling pathways. Its nitric-oxide synthase inhibitor activity reduces bioavailable NO, impairing endothelial function and vascular homeostasis. Cav1 is a well-established biomarker and effector of cellular senescence — it is strongly upregulated during replicative and stress-induced senescence and contributes to the senescence-associated secretory phenotype (SASP) by modulating p53/p21 and Ras/MAPK pathways. Its protein tyrosine kinase inhibitor activity dampens growth factor receptor signaling (e.g., EGFR, VEGFR), and its small GTPase binding suppresses Rac1/Ras-mediated proliferative and survival signals. Collectively, Cav1 overactivity promotes senescence entry and impairs tissue regeneration, making its normal function net anti-longevity in mice.",
"confidence": 0.72,
"key_pathways": [
"cellular senescence / p53-p21 axis",
"nitric oxide synthase inhibition / endothelial dysfunction",
"receptor tyrosine kinase / small GTPase signaling suppression"
],
"mechanism_class": "cellular_senescence",
"longevity_influence": "anti_longevity"
}advisor
{
"notes": "The model predicted anti_longevity with 0.72 confidence, but the ground truth is pro_longevity. The model's reasoning about Cav1 promoting senescence is partially grounded in real biology (Cav1 is indeed upregulated in senescent cells), but it drew the wrong conclusion about the net effect on longevity. In mice, Cav1 knockout studies show reduced lifespan and accelerated aging phenotypes, indicating Cav1 is pro-longevity. The model correctly identified some Cav1 biology (senescence association, NOS inhibition, kinase inhibitor activity) but misinterpreted the direction of effect — conflating Cav1's upregulation during senescence with it being a driver of aging rather than a protective/homeostatic factor. The mechanism reasoning is also incorrect in its conclusion.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}